Blue-Chip Stock Lower on Slashed Full-Year Outlook — Negative
SHW Schaeffers Research — July 22, 2025Dow Jones Industrial Average (DJI) member Sherwin-Williams Co (NYSE:SHW) reported a second-quarter profit miss of $3.38 per share earlier, while revenue came in slightly above estimates at $6.3 billion.

GM's Earnings Are a Warning Sign as August Tariff Deadline Looms — Negative
GM Barrons — July 22, 2025Profit margins for the auto maker's North American business were 4.8%, down nearly five percentage points from the second quarter last year.

Johnson Outdoors to Release Fiscal 2025 Third Quarter Results on August 1, 2025 — Neutral
JOUT GlobeNewsWire — July 22, 2025RACINE, Wis., July 22, 2025 (GLOBE NEWSWIRE) -- J OHNSON O UTDOORS I NC . (Nasdaq: JOUT), a leading global innovator of outdoor recreation equipment and technology, will release financial results for the Fiscal 2025 third quarter on Friday, August 1, 2025, before market open that day. The Company will host a conference call and audio webcast shortly afterwards at 11:00 a.m. Eastern Time to discuss the financial results and provide a Company update.

AECOM announces expiration and results of offer to purchase 5.125% Senior Notes due 2027 — Neutral
ACM Business Wire — July 22, 2025DALLAS--(BUSINESS WIRE)--AECOM (NYSE: ACM) today announced that its previously announced cash tender offer (the “Tender Offer”) for any and all of its 5.125% senior notes due 2027 (the “Notes”) expired at 5:00 p.m. New York City time, on July 21, 2025 (the “Expiration Date”). According to information provided by D.F. King and Co., Inc., the Tender and Information Agent for the Tender Offer, $732,914,000 aggregate principal amount of the Notes, or 73.49% of the aggregate principal amount outstan.

How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings? — Positive
ABBV Zacks Investment Research — July 22, 2025ABBV's neuroscience sales are projected to jump 15% in Q2, driven by Botox Therapeutic, Vraylar and oral migraine drug gains.

SRPT Slides on Voluntary US Elevidys Shipment Pause Amid Scrutiny — Negative
SRPT Zacks Investment Research — July 22, 2025Sarepta stock down as it halts U.S. Elevidys shipments after FDA pressure and safety concerns tied to patient deaths due to liver failure.

Applied Materials (AMAT) Recently Broke Out Above the 20-Day Moving Average — Positive
AMAT Zacks Investment Research — July 22, 2025After reaching an important support level, Applied Materials (AMAT) could be a good stock pick from a technical perspective. AMAT surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.

North American Construction (NOA) Loses 8.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner — Negative
NOA Zacks Investment Research — July 22, 2025North American Construction (NOA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Here's Why CVS Health (CVS) is Poised for a Turnaround After Losing 7.7% in 4 Weeks — Neutral
CVS Zacks Investment Research — July 22, 2025CVS Health (CVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Steris (STE) Loses 6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner — Negative
STE Zacks Investment Research — July 22, 2025Steris (STE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Auto Stock Eyes Worst Day Since March After Earnings — Negative
GM Schaeffers Research — July 22, 2025General Motors Co (NYSE:GM) stock is down 7% at $49.58 this morning, sliding lower despite the vehicle manufacturer's second-quarter earnings and revenue beat.

American Tower to Report Q2 Earnings: What to Expect From the Stock? — Positive
AMT Zacks Investment Research — July 22, 2025AMT's Q2 results may show revenue and AFFO declines, but strength in services and data centers may have offered support.

Brokers Suggest Investing in Zscaler (ZS): Read This Before Placing a Bet — Negative
ZS Zacks Investment Research — July 22, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Invesco (IVZ) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive
IVZ Zacks Investment Research — July 22, 2025Although the revenue and EPS for Invesco (IVZ) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Wall Street Bulls Look Optimistic About AZZ (AZZ): Should You Buy? — Positive
AZZ Zacks Investment Research — July 22, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Here's What Key Metrics Tell Us About Equifax (EFX) Q2 Earnings — Neutral
EFX Zacks Investment Research — July 22, 2025While the top- and bottom-line numbers for Equifax (EFX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Brokers Suggest Investing in Cadence (CDNS): Read This Before Placing a Bet — Negative
CDNS Zacks Investment Research — July 22, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Peoples Bancorp (PEBO) Reports Q2 Earnings: What Key Metrics Have to Say — Positive
PEBO Zacks Investment Research — July 22, 2025The headline numbers for Peoples Bancorp (PEBO) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Earnings Growth & Price Strength Make Huntington Ingalls (HII) a Stock to Watch — Positive
HII Zacks Investment Research — July 22, 2025The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Is It Worth Investing in Comfort Systems (FIX) Based on Wall Street's Bullish Views? — Neutral
FIX Zacks Investment Research — July 22, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
